Xenetic Biosciences XBIO
NASDAQ XBIO
$2.24 +0.01 (+0.45%)
As of: Oct 2, 2026 · 1:31 PM EDT

Xenetic Biosciences (XBIO) Net Equity Issued and Repurchased (2012 - 2019)

Updated

Xenetic Biosciences' Net Equity Issued and Repurchased came in at $4 million for FY2025.

Analysis

Xenetic Biosciences (XBIO) Net Equity Issued and Repurchased (2012 - 2019) Analysis & Trends

Going back to FY2011, Xenetic Biosciences' Net Equity Issued and Repurchased data covers 8 years.

  • Net Equity Issued and Repurchased carries a four-year compound annual growth rate of 474.4% (FY2021 to FY2025).
  • The FY2025 figure represents the highest annual Net Equity Issued and Repurchased since FY2019.
  • Per Business Quant, earlier years put Net Equity Issued and Repurchased at $3,679 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 Xenetic Biosciences 5.44 Mn -20.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 10.72 Mn
Sep 30, 2019 -10.70 Mn
Mar 31, 2019 2.70 Mn
Jun 30, 2018 1.48 Mn
Mar 31, 2014 10.00 Mn
May 31, 2012 25,000.00
API Access

Xenetic Biosciences Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XBIO&period=max&api_key=YOUR_API_KEY